HopeStage
Back to all studies
CompletedNCT05712187

ALTO-100 study for adults with major depression

About this titleRead the official source — NCT05712187

Researchers compared ALTO-100 and placebo to find out how the approaches affected depression symptoms in adults with depression.

Medication studyAges 18–64United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared ALTO-100 and placebo to find out how the approaches affected depression symptoms in adults with depression.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.

Listed locations
Birmingham and 33 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 10, 2023
Recruitment status
Completed
Enrollment listed in the registry
301
Sponsor
Alto Neuroscience
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT05712187
Official title
Show the full official title

A Randomized, Double-Blind, Placebo-Controlled Study of ALTO-100 With an Open-Label Extension in Adults With Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Huntsville · Chandler

26 more locations
  • Little Rock
  • Costa Mesa
  • Fresno
  • Imperial
  • Oceanside
  • Rancho Cucamonga
  • Sacramento
  • Centennial
  • Brooksville
  • Jacksonville
  • Orlando
  • Tampa
  • Carmel
  • Baltimore
  • Jackson
  • Lincoln
  • Las Vegas
  • Albuquerque
  • Brooklyn
  • New York
  • Westlake
  • North Charleston
  • Memphis
  • Fort Worth
  • Houston
  • Draper

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared ALTO-100 and placebo to find out how the approaches affected depression symptoms in adults with depression.

Who is behind this study?

The study sponsor is Alto Neuroscience.

Did this study involve medication?

Yes. The study involved medication, including ALTO-100 and Placebo.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies